01-671-943
beta Lactamase Monoclonal Antibody (3E11.G3), Invitrogen™
Manufacturer: Fischer Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | 01-671-943-Each-of-1 | In Stock | ₹ 50,774.50 |
01-671-943 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 50,774.50
GST (18%): ₹ 9,139.41
Total Price: ₹ 59,913.91
Antigen
beta Lactamase
Classification
Monoclonal
Concentration
0.5 mg/mL
Formulation
PBS with no preservative; pH 7.4
Host Species
Mouse
Purification Method
Protein A
Regulatory Status
RUO
Target Species
Bacteria
Product Type
Antibody
Isotype
IgG3
Applications
ELISA
Clone
3E11.G3
Conjugate
Unconjugated
Gene Alias
blaCTX-M-14; FLJ14902; G24; lactamase beta; LACTB; mitochondrial 39S ribosomal protein L56; MRPL56; Serine beta-lactamase-like protein LACTB, mitochondrial; UNQ843/PRO1781
Immunogen
Type IV beta-lactamase from Enterobacter cloacae.
Quantity
500 μg
Primary or Secondary
Primary
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Related Products
Description
- MA1-10713 detects beta Lactamase from Enterobacter cloacae samples
- MA1-10713 has been successfully used in ELISA applications
- The MA1-10713 immunogen is Type IV beta-lactamase from Enterobacter cloacae
- The beta lactam antibiotics (penicillins and cephalosporins) are the most frequently used antimicrobial agents
- All of the beta lactams are structurally related through the presence of a core beta lactam ring
- Bacterial resistance to beta lactams continues to increase, primarily due to the production of beta lactamases
- Beta lactamases catalyze the hydrolysis of the beta lactam bond, which destroys antibacterial activity
- Bacteria that produce TEM type or SHV type beta lactamases have point mutations in structural genes that have extended the substrate specificity of these beta lactamases
- As a result, many of the beta lactamase producing Gram negative pathogens have become multidrug resistant.